Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mechoulam

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|November 5, 1997
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclaseM H Rhee, Z Vogel, J Barg, et al.
NIDA Research Monograph|January 1, 1987
Structure-anticonvulsant activity relationships of cannabidiol analogsA R Martin, P Consroe, V V Kane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptorL Hanus, S Abu-Lafi, E Fride, et al.
Journal of Medicinal Chemistry|August 21, 1992
Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activitiesS H Burstein, C A Audette, A Breuer, et al.
Journal of Medicinal Chemistry|October 1, 1980
Stereochemical requirements for cannabinoid activityR Mechoulam, N Lander, T H Varkony, et al.
Pharmaceutical Research|January 1, 1996
Derivatives of Dexanabinol. I. Water-soluble salts of glycinate estersE Pop, Z Z Liu, M E Brewster, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1979
Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinolS Agurell, C Edward, M Halldin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoidR Gallily, A Yamin, Y Waksmann, et al.
Molecular Pharmacology|February 26, 2011
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseAna María Martín-Moreno, David Reigada, Belén G Ramírez, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|November 5, 1997
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclaseM H Rhee, Z Vogel, J Barg, et al.
NIDA Research Monograph|January 1, 1987
Structure-anticonvulsant activity relationships of cannabidiol analogsA R Martin, P Consroe, V V Kane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptorL Hanus, S Abu-Lafi, E Fride, et al.
Journal of Medicinal Chemistry|August 21, 1992
Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activitiesS H Burstein, C A Audette, A Breuer, et al.
Journal of Medicinal Chemistry|October 1, 1980
Stereochemical requirements for cannabinoid activityR Mechoulam, N Lander, T H Varkony, et al.
Pharmaceutical Research|January 1, 1996
Derivatives of Dexanabinol. I. Water-soluble salts of glycinate estersE Pop, Z Z Liu, M E Brewster, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1979
Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinolS Agurell, C Edward, M Halldin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoidR Gallily, A Yamin, Y Waksmann, et al.
Molecular Pharmacology|February 26, 2011
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseAna María Martín-Moreno, David Reigada, Belén G Ramírez, et al.
Pageof 19